Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutatons: a follow-on phase 1 trial
暂无分享,去创建一个
Kathleen A. Marshall | O. Elci | K. High | F. Mingozzi | J. Bennicelli | Junwei Sun | J. Wellman | L. Cyckowski | Sarah Mccague | Julie DiStefano-Pappas | Dominique Cross | Puya Aravand | Jason Ruggiero | J. F. Wright | Manzar Ashtari | Prof Jean Bennett | Daniel C Chung | Alberto | Auricchio | Eric A. Pierce | Bart P. Leroy | Francesca | Simonelli